OPTASE ALLEGRO- hydroxyethyl cellulose solution/ drops 
Scope Health Inc

----------

Optase Allegro Eye Drops

0.35% Hydroxyethyl Cellulose

Keep out of reach of children.
If swallowed get medical
help or contact a poison
control center right away.

Eye Lubricant


Inactive ingredients: Citric Acid,
Ectoin, Purified Water, Sodium
Chloride, Trisodium Citrate Dihydrate.

Directions:
Put one or two drops in the
affected eyes as needed.

Warning
• For external use only.
• If solution changes color or
becomes cloudy, do not use.

To avoid contamination, do

not touch tip to any surface.

After use, shake the bottle

downwards in order to remove
any residual drop that may be left.
Replace cap after using.
Stop use and ask doctor if:


Stop use and ask doctor if
• You feel eye pain.
• Changes in vision occur.
• Redness or irritation of the eye lasts.
• Condition worsens or lasts
more than 72 hours

Uses
• For use as a lubricant to prevent
further irritation.
• May be used as a protectant against
further irritation.
• To relieve dryness of the eye.

Patient Information Leaflet

Optase Allegro

Optase Allegro

Immediate Label

Optase Allegro

OPTASE ALLEGRO 
hydroxyethyl cellulose solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72972-006
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROXYETHYL CELLULOSE (140 CPS AT 5%) (UNII: 8136Y38GY5) (HYDROXYETHYL CELLULOSE (140 CPS AT 5%) - UNII:8136Y38GY5) HYDROXYETHYL CELLULOSE (140 CPS AT 5%)0.35 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ECTOINE (UNII: 7GXZ3858RY)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72972-006-011 in 1 BOX03/23/2023
110 mL in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01803/23/2023
Labeler - Scope Health Inc (116778693)
Registrant - Regulatory Matters Consulting (080711165)

Revised: 11/2023
Document Id: 0a7b7ced-34ed-7921-e063-6294a90a78ea
Set id: f7999928-f5c1-98d6-e053-6294a90a57db
Version: 2
Effective Time: 20231119
 
Scope Health Inc